SI1965773T1 - Oralna formulacija anhidridnega olanzapina oblike i - Google Patents
Oralna formulacija anhidridnega olanzapina oblike iInfo
- Publication number
- SI1965773T1 SI1965773T1 SI200631050T SI200631050T SI1965773T1 SI 1965773 T1 SI1965773 T1 SI 1965773T1 SI 200631050 T SI200631050 T SI 200631050T SI 200631050 T SI200631050 T SI 200631050T SI 1965773 T1 SI1965773 T1 SI 1965773T1
- Authority
- SI
- Slovenia
- Prior art keywords
- core
- olanzapine
- salt
- anhydrous
- functional polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200503183A ES2279715B1 (es) | 2005-12-26 | 2005-12-26 | Formulacion oral de olanzapina. |
US75410405P | 2005-12-27 | 2005-12-27 | |
PCT/EP2006/069905 WO2007074110A1 (en) | 2005-12-26 | 2006-12-19 | Oral formulation of anhydrous olanzapine form i |
EP06841451A EP1965773B1 (en) | 2005-12-26 | 2006-12-19 | Oral formulation of anhydrous olanzapine form i |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1965773T1 true SI1965773T1 (sl) | 2011-09-30 |
Family
ID=38468505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200631050T SI1965773T1 (sl) | 2005-12-26 | 2006-12-19 | Oralna formulacija anhidridnega olanzapina oblike i |
Country Status (13)
Country | Link |
---|---|
US (1) | US8962018B2 (sl) |
EP (1) | EP1965773B1 (sl) |
JP (1) | JP2009521518A (sl) |
KR (1) | KR20080080230A (sl) |
AT (1) | ATE504292T1 (sl) |
CY (1) | CY1111666T1 (sl) |
DE (1) | DE602006021231D1 (sl) |
DK (1) | DK1965773T3 (sl) |
ES (2) | ES2279715B1 (sl) |
PL (1) | PL1965773T3 (sl) |
PT (1) | PT1965773E (sl) |
SI (1) | SI1965773T1 (sl) |
WO (1) | WO2007074110A1 (sl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0522473D0 (en) * | 2005-11-03 | 2005-12-14 | Actavis Group | A pharmaceutical formulation |
TWI399223B (zh) * | 2006-09-15 | 2013-06-21 | Daiichi Sankyo Co Ltd | 奧美沙坦酯及氨氯地平之固體劑型 |
WO2012014012A1 (es) * | 2010-07-27 | 2012-02-02 | Laboratorios Andrómaco S.A. | Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia. |
SI2612681T1 (sl) * | 2010-08-31 | 2019-05-31 | Toray Industries, Inc. | Obložno sredstvo za farmacevtsko trdno obliko, farmacevtska filmska formulacija in obložena farmacevtska trdna oblika |
GB201400034D0 (en) * | 2014-01-02 | 2014-02-19 | Astrazeneca Ab | Pharmaceutical Compositions comprising AZD9291 |
CN104546807B (zh) * | 2015-01-21 | 2020-09-01 | 齐鲁制药有限公司 | 奥氮平口腔速溶膜剂 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4115568A (en) | 1974-11-26 | 1978-09-19 | Lilly Industries Limited | Thieno[3,2-b]-[1,5]benzodiazepines |
US5229382A (en) | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
CN1097619C (zh) | 1994-07-12 | 2003-01-01 | 伯温德药品服务公司 | 隔潮膜涂层组合物及其生产方法以及涂层制品 |
CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
US5631250A (en) * | 1995-03-24 | 1997-05-20 | Eli Lilly And Company | Process and solvate of 2-methyl-thieno-benzodiazepine |
EG23659A (en) | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
JP2001501207A (ja) * | 1996-09-24 | 2001-01-30 | イーライ・リリー・アンド・カンパニー | コーティングされた粒子製剤 |
US5843477A (en) * | 1997-09-30 | 1998-12-01 | Bayer Corporation | Lubricants for use in tabletting |
US7612112B2 (en) * | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
US6906062B2 (en) | 2001-12-24 | 2005-06-14 | Sun Pharmaceutical Industries Limited | Crystalline form I of 2-methyl-4-(4-menthyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine |
SI1476138T1 (sl) * | 2002-02-21 | 2012-07-31 | Valeant Internat Barbados Srl | Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola |
PL196814B1 (pl) | 2002-05-17 | 2008-02-29 | Inst Farmaceutyczny | Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty |
EP1513846B1 (en) | 2002-05-31 | 2011-03-02 | Sandoz Ag | Process of preparation of olanzapine form i |
SI21303A (sl) | 2002-10-18 | 2004-04-30 | Krka, Tovarna Zdravil, D.D.,, Novo Mesto | Farmacevtska formulacija olanzapina |
AU2003299983A1 (en) | 2002-12-20 | 2004-07-22 | St. James Associates Llc/Faber Research Series | High pressure compaction for pharmaceutical formulations |
WO2005009407A2 (en) | 2003-07-29 | 2005-02-03 | Ranbaxy Laboratories Limited | Oral pharmaceutical formulations of olanzapine |
AR047459A1 (es) * | 2004-01-27 | 2006-01-18 | Synthon Bv | Sales estables de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b][1,5]benzodiazepina (olanzapina) |
ES2253091B1 (es) | 2004-07-27 | 2007-02-01 | Inke, S.A. | Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo. |
GB0522474D0 (en) | 2005-11-03 | 2005-12-14 | Actavis Group | A pharmaceutical formulation |
-
2005
- 2005-12-26 ES ES200503183A patent/ES2279715B1/es active Active
-
2006
- 2006-12-19 US US12/159,030 patent/US8962018B2/en active Active
- 2006-12-19 ES ES06841451T patent/ES2359647T3/es active Active
- 2006-12-19 WO PCT/EP2006/069905 patent/WO2007074110A1/en active Application Filing
- 2006-12-19 PL PL06841451T patent/PL1965773T3/pl unknown
- 2006-12-19 PT PT06841451T patent/PT1965773E/pt unknown
- 2006-12-19 EP EP06841451A patent/EP1965773B1/en not_active Revoked
- 2006-12-19 KR KR1020087018344A patent/KR20080080230A/ko not_active Application Discontinuation
- 2006-12-19 AT AT06841451T patent/ATE504292T1/de active
- 2006-12-19 DE DE602006021231T patent/DE602006021231D1/de active Active
- 2006-12-19 SI SI200631050T patent/SI1965773T1/sl unknown
- 2006-12-19 JP JP2008547947A patent/JP2009521518A/ja not_active Withdrawn
- 2006-12-19 DK DK06841451.5T patent/DK1965773T3/da active
-
2011
- 2011-07-05 CY CY20111100651T patent/CY1111666T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1965773B1 (en) | 2011-04-06 |
PT1965773E (pt) | 2011-07-12 |
CY1111666T1 (el) | 2015-10-07 |
DK1965773T3 (da) | 2011-07-25 |
ES2279715A1 (es) | 2007-08-16 |
WO2007074110A1 (en) | 2007-07-05 |
KR20080080230A (ko) | 2008-09-02 |
US8962018B2 (en) | 2015-02-24 |
DE602006021231D1 (de) | 2011-05-19 |
ES2359647T3 (es) | 2011-05-25 |
US20080311203A1 (en) | 2008-12-18 |
ATE504292T1 (de) | 2011-04-15 |
ES2279715B1 (es) | 2008-06-01 |
PL1965773T3 (pl) | 2011-11-30 |
JP2009521518A (ja) | 2009-06-04 |
EP1965773A1 (en) | 2008-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111666T1 (el) | Απο του στοματος συνθεση ανυδρης ολανζαπινης μορφης 1 | |
WO2007092620A3 (en) | Stable formulations, and methods of their preparation and use | |
TW200716202A (en) | Pediatric formulation of topiramate | |
TNSN08061A1 (en) | Liquid formulations | |
UA104902C2 (uk) | Фармацевтичні композиції для запобігання зловживанню лікарськими препаратами | |
EA201001402A1 (ru) | Фармацевтические растворы, способ получения и терапевтическое применение | |
DE602006012725D1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung | |
NO20093146L (no) | Amino-pyridinderivater som S1P1/EDG1-reseptoragonister | |
AR065096A1 (es) | Preparacion solida | |
NO20075111L (no) | Farmasoytisk sammensetning | |
WO2007016388A3 (en) | Liquid formulations for controlled delivery of benzisoxazole derivatives | |
CL2013001885A1 (es) | Compuestos derivados de morfina, antagonistas del receptor ipiode periferico; composicion farmaceutica; formulacion oral; y uso para reducir los efectos colaterales de la terapia opioide (div. sol. 905-08). | |
RS53363B (en) | ORAL PHARMACEUTICAL TABLETS FOR THE CONTROLLED MESALAZINE RELEASE AND THE PROCESS OF OBTAINING THEM | |
WO2009123714A3 (en) | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor | |
CL2011000044A1 (es) | Uso de una composicion farmaceutica oral que comprende al menos un antagonista opioide seleccionado de naloxona, naltrexona, nalbufino o sus sales, adicionalmente puede comprender al menos un agonista opioide, tal como oxicodona, morfina u otros, para el tratamiento de la retencion urinaria. | |
DE602006018713D1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
DE602006015509D1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung | |
UA107353C2 (en) | Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof | |
MX2010009756A (es) | Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos. | |
MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
WO2008074833A3 (en) | Compounds | |
PE20071315A1 (es) | Formulaciones de compuestos derivados de fenilo y procesos de preparacion para tabletas que contienen dichos compuestos | |
TW200800977A (en) | A new salt | |
WO2006087358A3 (en) | Composition for adjusting water quality for administration of water sanitizer sensitive medicaments or vaccines | |
WO2011090725A3 (en) | Gastroretentive solid oral dosage forms with swellable hydrophilic polymer |